Diabetes complications

Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study

Cardiovasc DiabetolPublished Prospective cohort study

Authors' conclusion

This study represents the first demonstration of an independent relationship between a non-invasive liver fibrosis test and the progression of lower limb arterial calcification in patients with T2D. Beyond its utility in assessing liver fibrosis, the FibroTest® could be a valuable and easy-to-use biomarker for predicting the risk of worsening lower limb arterial calcification.

Study context

Population
Patients with T2D; Lower limb arterial calcification score (LLACS) by CT at baseline and after mean follow-up of 31.2 ± 3.7 months
Participants
150 patients
Outcome
Association of MASLD biomarkers (FibroMax® panels: SteatoTest®, FibroTest®, NashTest®, ActiTest®) with annualized change in LLACS
Follow-up
Average 31.2 ± 3.7 months

Main finding

As reported in the abstract

Annualized change in LLACS
Univariate correlation with baseline LLACS
r = 0.860, p < 0.0001
Univariate correlation with FibroTest® score
r = 0.304, p = 0.0002
Univariate correlation with age
r = 0.275, p = 0.0006
Univariate correlation with glomerular filtration rate (negative)
r = - 0.242, p = 0.003
FibroTest® score β, multivariate, adjusted for baseline LLACS and lower extremity artery disease risk factors
988, p = 0.006 (95% CI 284-1692)
FibroTest® score β, adjusted for variables selected by principal component analysis
1029, p = 0.007 (CI 289-1768)

Observational data: associations, not effects.

Further findings

LLACS increased during follow-up

Patients with increased LLACS
127 (85%) of 150

Original publication

Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study. Cardiovasc Diabetol. Published 23 April 2025. doi:10.1186/s12933-025-02705-9

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.